# City Holding Co: financial statements, quarterly

CHCO · Nasdaq · CIK 726854 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/chco.md) · [Financials](/companies/chco/financials.md) · [Filings](/companies/chco/filings.md) · [Insiders](/companies/chco/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/chco/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [14.6](/filings/0000726854-23-000156.md) | [17.2 d](/filings/0000726854-24-000040.md) | [19.1](/filings/0000726854-24-000135.md) | [21.4](/filings/0000726854-24-000168.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [8.0](/filings/0000726854-24-000204.md) | [6.6 d](/filings/0000726854-26-000062.md) | [7.1](/filings/0000726854-25-000130.md) | [7.1](/filings/0000726854-25-000163.md) | [7.3](/filings/0000726854-25-000178.md) | [5.8 d](/filings/0000726854-26-000062.md) | [6.6](/filings/0000726854-26-000122.md) | [7.8](/filings/0000726854-26-000164.md) | [8.7](/filings/0000726854-25-000178.md) | [8.0 d](/filings/0000726854-26-000062.md) | [7.5](/filings/0000726854-26-000122.md) | [8.0](/filings/0000726854-26-000164.md) |
| Net income | $m | [29.8](/filings/0000726854-24-000204.md) | [27.5 d](/filings/0000726854-26-000062.md) | [29.5](/filings/0000726854-25-000130.md) | [29.1](/filings/0000726854-25-000163.md) | [29.8](/filings/0000726854-25-000178.md) | [28.7 d](/filings/0000726854-26-000062.md) | [30.3](/filings/0000726854-26-000122.md) | [33.4](/filings/0000726854-26-000164.md) | [35.2](/filings/0000726854-25-000178.md) | [31.6 d](/filings/0000726854-26-000062.md) | [31.7](/filings/0000726854-26-000122.md) | [33.3](/filings/0000726854-26-000164.md) |
| Diluted EPS | $ per share | [1.98](/filings/0000726854-24-000204.md) | not reported | [1.97](/filings/0000726854-25-000130.md) | [1.96](/filings/0000726854-25-000163.md) | [2.02](/filings/0000726854-25-000178.md) | not reported | [2.06](/filings/0000726854-26-000122.md) | [2.29](/filings/0000726854-26-000164.md) | [2.41](/filings/0000726854-25-000178.md) | not reported | [2.20](/filings/0000726854-26-000122.md) | [2.35](/filings/0000726854-26-000164.md) |
| Basic EPS | $ per share | [1.98](/filings/0000726854-24-000204.md) | not reported | [1.98](/filings/0000726854-25-000130.md) | [1.96](/filings/0000726854-25-000163.md) | [2.02](/filings/0000726854-25-000178.md) | not reported | [2.06](/filings/0000726854-26-000122.md) | [2.29](/filings/0000726854-26-000164.md) | [2.41](/filings/0000726854-25-000178.md) | not reported | [2.20](/filings/0000726854-26-000122.md) | [2.35](/filings/0000726854-26-000164.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [111](/filings/0000726854-23-000156.md) | [156](/filings/0000726854-25-000037.md) | [319](/filings/0000726854-24-000135.md) | [218](/filings/0000726854-24-000168.md) | [294](/filings/0000726854-24-000204.md) | [225](/filings/0000726854-26-000062.md) | [385](/filings/0000726854-25-000130.md) | [172](/filings/0000726854-25-000163.md) | [226](/filings/0000726854-25-000178.md) | [192](/filings/0000726854-26-000164.md) | [299](/filings/0000726854-26-000122.md) | [267](/filings/0000726854-26-000164.md) |
| Total assets | $m | [6,076](/filings/0000726854-23-000156.md) | [6,168](/filings/0000726854-25-000037.md) | [6,314](/filings/0000726854-24-000135.md) | [6,341](/filings/0000726854-24-000168.md) | [6,434](/filings/0000726854-24-000204.md) | [6,459](/filings/0000726854-26-000062.md) | [6,623](/filings/0000726854-25-000130.md) | [6,598](/filings/0000726854-25-000163.md) | [6,668](/filings/0000726854-25-000178.md) | [6,722](/filings/0000726854-26-000164.md) | [6,760](/filings/0000726854-26-000122.md) | [6,774](/filings/0000726854-26-000164.md) |
| Total liabilities | $m | [5,466](/filings/0000726854-23-000156.md) | [5,491](/filings/0000726854-25-000037.md) | [5,632](/filings/0000726854-24-000135.md) | [5,655](/filings/0000726854-24-000168.md) | [5,693](/filings/0000726854-24-000204.md) | [5,729](/filings/0000726854-26-000062.md) | [5,867](/filings/0000726854-25-000130.md) | [5,834](/filings/0000726854-25-000163.md) | [5,869](/filings/0000726854-25-000178.md) | [5,912](/filings/0000726854-26-000164.md) | [5,966](/filings/0000726854-26-000122.md) | [5,965](/filings/0000726854-26-000164.md) |
| Long-term debt | $m | [100](/filings/0000726854-23-000156.md) | [100](/filings/0000726854-25-000037.md) | [150](/filings/0000726854-24-000135.md) | [150](/filings/0000726854-24-000168.md) | [150](/filings/0000726854-24-000204.md) | [150](/filings/0000726854-26-000062.md) | [150](/filings/0000726854-25-000130.md) | [150](/filings/0000726854-25-000163.md) | [150](/filings/0000726854-25-000178.md) | [150](/filings/0000726854-26-000164.md) | [150](/filings/0000726854-26-000122.md) | [150](/filings/0000726854-26-000164.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [610](/filings/0000726854-24-000204.md) | [677](/filings/0000726854-26-000062.md) | [682](/filings/0000726854-25-000163.md) | [687](/filings/0000726854-25-000178.md) | [741](/filings/0000726854-25-000178.md) | [731](/filings/0000726854-26-000164.md) | [756](/filings/0000726854-26-000164.md) | [764](/filings/0000726854-26-000164.md) | [799](/filings/0000726854-25-000178.md) | [810](/filings/0000726854-26-000164.md) | [794](/filings/0000726854-26-000164.md) | [809](/filings/0000726854-26-000164.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [36.7 d](/filings/0000726854-24-000204.md) | [33.5 d](/filings/0000726854-26-000062.md) | [32.2](/filings/0000726854-25-000130.md) | [28.3 d](/filings/0000726854-25-000163.md) | [37.6 d](/filings/0000726854-25-000178.md) | [33.8 d](/filings/0000726854-26-000062.md) | [31.5](/filings/0000726854-26-000122.md) | [28.1 d](/filings/0000726854-26-000164.md) | [37.4 d](/filings/0000726854-25-000178.md) | [34.3 d](/filings/0000726854-26-000062.md) | [38.0](/filings/0000726854-26-000122.md) | [32.6 d](/filings/0000726854-26-000164.md) |
| Capital expenditure | $m | [0.7 d](/filings/0000726854-24-000204.md) | [0.6 d](/filings/0000726854-26-000062.md) | [0.6](/filings/0000726854-25-000130.md) | [0.5 d](/filings/0000726854-25-000163.md) | [0.6 d](/filings/0000726854-25-000178.md) | [1.0 d](/filings/0000726854-26-000062.md) | [0.3](/filings/0000726854-26-000122.md) | [0.4 d](/filings/0000726854-26-000164.md) | [1.5 d](/filings/0000726854-25-000178.md) | [0.7 d](/filings/0000726854-26-000062.md) | [0.7](/filings/0000726854-26-000122.md) | [0.8 d](/filings/0000726854-26-000164.md) |
| Dividends paid | $m | [9.8 d](/filings/0000726854-24-000204.md) | [10.6 d](/filings/0000726854-26-000062.md) | [10.6](/filings/0000726854-25-000130.md) | [10.8 d](/filings/0000726854-25-000163.md) | [10.5 d](/filings/0000726854-25-000178.md) | [11.6 d](/filings/0000726854-26-000062.md) | [11.6](/filings/0000726854-26-000122.md) | [11.6 d](/filings/0000726854-26-000164.md) | [11.5 d](/filings/0000726854-25-000178.md) | [12.6 d](/filings/0000726854-26-000062.md) | [14.8](/filings/0000726854-26-000122.md) | [10.1 d](/filings/0000726854-26-000164.md) |
| Share repurchases | $m | [9.8 d](/filings/0000726854-24-000204.md) | [6.3 d](/filings/0000726854-26-000062.md) | [3.7](/filings/0000726854-25-000130.md) | [14.2 d](/filings/0000726854-25-000163.md) | [0.0 d](/filings/0000726854-25-000178.md) | [0.0 d](/filings/0000726854-26-000062.md) | [9.5](/filings/0000726854-26-000122.md) | [19.4 d](/filings/0000726854-26-000164.md) | [0.0 d](/filings/0000726854-25-000178.md) | [16.9 d](/filings/0000726854-26-000062.md) | [30.9](/filings/0000726854-26-000122.md) | [7.3 d](/filings/0000726854-26-000164.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.8](/filings/0000726854-23-000015.md) | [14.8](/filings/0000726854-24-000135.md) | [15.0](/filings/0000726854-24-000168.md) | [14.9](/filings/0000726854-24-000204.md) | [14.8](/filings/0000726854-25-000130.md) | [14.7](/filings/0000726854-25-000163.md) | [14.7](/filings/0000726854-25-000178.md) | [14.6](/filings/0000726854-26-000122.md) | [14.5](/filings/0000726854-26-000164.md) | [14.5](/filings/0000726854-25-000178.md) | [14.3](/filings/0000726854-26-000122.md) | [14.1](/filings/0000726854-26-000164.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,045,160 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0000726854-26-000164.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.